Sunitinib gets the gist in imatinib-resistance

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1491, 2005-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Horizons expanded for sunitinib in GIST

By  

Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

SMC accepts imatinib for GIST

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 652, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Imatinib/sunitinib: Rhabdomyosarcomatous differentiation (first report) and TKI resistance: 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1243, 2009-01 ,pp. : 27-28

Adis International

Access to resources Recommend Favorite

Adjuvant imatinib worth the cost in GIST patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 617, 2010-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Imatinib for priority review by US FDA for GIST recurrence.

By  

Inpharma, Vol. 1, Iss. 1654, 2008-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite